This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cesta, M. F. Articles by Malarkey, D. E. Search for Related Content PubMed PubMed Citation Articles by Cesta, M. F. Articles by Malarkey, D. E. Social Bookmarking                            What's this?

Pathology of End-stage Remodeling in a Family of Cats with Hypertrophic Cardiomyopathy

National Institute of Environmental Health Sciences (NIEHS), Laboratory of Experimental Pathology, Research Triangle Park, NC (DM, MC); University of Pittsburgh School of Medicine, Department of Cell Biology and Physiology, Pittsburgh, PA (CB); and Departments of Clinical Sciences (BK) and Molecular Biomedical Sciences (IS), North Carolina State University College of Veterinary Medicine, Raleigh, NC

End-stage hypertrophic cardiomyopathy (ES-HCM), affecting 5–10% of human hypertrophic cardiomyopathy (HCM) patients, is characterized by relative thinning of the ventricular walls and septum with dilation of the ventricular lumen, decreased fractional shortening, and progression to heart failure. C. J. Baty and others recently documented similar progressive changes to ES-HCM in a family of four cats through serial echocardiograms. At the time of heart failure, these cats exhibited changes similar to those exhibited by human ES-HCM patients. Our objectives were to describe the pathologic alterations associated with ES-HCM and investigate the pathogenesis in three of the four cats. Grossly, there was left atrial dilation with relative thinning of the interventricular septum (IVS) and left ventricular free wall (LVFW). The left atrium contained large thrombi in two of the three cats, and all three cats died following thromboembolization of the aortic bifurcation. Histologically, all three cats had subendocardial and myocardial fibrosis, predominantly of the IVS and LVFW, and one cat had acute, multifocal, myocardial infarcts with mononuclear inflammatory cell infiltrates. The pathogenesis of ES-HCM is uncertain, but theories implicate occlusion of the coronary blood flow by thickening of the coronary vessels, coronary vascular thromboembolism or coronary vessel spasm, apoptosis of myocytes, and myocardial hypertrophy beyond the ability of the vasculature to supply blood. Apoptosis assays did not reveal any apoptotic myocytes. Considering the hypercoagulative state of these cats, coronary vascular thromboembolism could be a major contributing factor. We cannot exclude apoptosis or coronary vessel spasm on the basis of the data presented.

Key words: Burned-out phase; dilated phase; end stage; feline; hypertrophic cardiomyopathy; myocardial fibrosis.

Request reprints from Dr. D. E. Malarkey, Laboratory of Experimental Pathology, NIEHS, Maildrop B3–06, PO Box 12233, Research Triangle Park, NC 27709 (USA). E-mail: malarkey{at}niehs.nih.gov

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?